Lonvoguran Ziclumeran — In Vivo CRISPR Gene Editing in Hereditary Angioedema

Danny M. Cohn

Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam

Padmalal Gurugama

Cambridge University Hospitals, NHS Foundation Trust, Cambridge, United Kingdom

Hilary J. Longhurst

Te Toka Tumai, Department of Immunology, Auckland City Hospital, Auckland, New Zealand

Emel Aygören-Pürsün

Department of Children and Adolescents, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany

Timothy J. Craig

Penn State University Departments of Medicine, Pediatrics, OB/GYN Maternal Fetal Medicine, and Biomedical Sciences, Hershey, PA

Henriette Farkas

Hungarian Angioedema Center of Reference and Excellence, Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary

Joshua Jacobs

Allergy and Asthma Clinical Research, Walnut Creek, CA

William R. Lumry

Markus Magerl

Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin

Jonny Peter

Division of Allergology and Clinical Immunology, Department of Medicine, Groote Schuur Hospital, University of Cape Town and Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa

Marc A. Riedl

University of California, San Diego, La Jolla

David Maag

Intellia Therapeutics, Cambridge, MA

Adele Golden

Intellia Therapeutics, Cambridge, MA

Mrinal Y. Shah

Intellia Therapeutics, Cambridge, MA

Andrea Sutherland

Intellia Therapeutics, Cambridge, MA

Catherine R. Miller

Intellia Therapeutics, Cambridge, MA

Ahmed M. Abdelhady

Intellia Therapeutics, Cambridge, MA

Yuanxin Xu

Intellia Therapeutics, Cambridge, MA

James S. Butler

Intellia Therapeutics, Cambridge, MA

David Lebwohl

Intellia Therapeutics, Cambridge, MA

John Leonard

Intellia Therapeutics, Cambridge, MA

Aleena Banerji

Massachusetts General Hospital, Boston